Johnson & Johnson (NYSE:JNJ) Plans Quarterly Dividend of $1.30

by · The Markets Daily

Johnson & Johnson (NYSE:JNJ – Get Free Report) announced a quarterly dividend on Friday, January 2nd. Shareholders of record on Tuesday, February 24th will be given a dividend of 1.30 per share on Tuesday, March 10th. This represents a c) annualized dividend and a yield of 2.5%. The ex-dividend date of this dividend is Tuesday, February 24th.

Johnson & Johnson has raised its dividend by an average of 0.1%per year over the last three years and has increased its dividend annually for the last 64 consecutive years. Johnson & Johnson has a payout ratio of 46.8% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Johnson & Johnson to earn $11.07 per share next year, which means the company should continue to be able to cover its $5.20 annual dividend with an expected future payout ratio of 47.0%.

Johnson & Johnson Stock Performance

Johnson & Johnson stock traded up $0.31 during mid-day trading on Friday, reaching $207.26. 6,321,416 shares of the company traded hands, compared to its average volume of 7,556,939. The firm’s fifty day moving average is $200.83 and its two-hundred day moving average is $182.27. The company has a market capitalization of $499.35 billion, a price-to-earnings ratio of 20.01, a price-to-earnings-growth ratio of 2.24 and a beta of 0.36. Johnson & Johnson has a fifty-two week low of $140.68 and a fifty-two week high of $215.18. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.07 and a quick ratio of 0.80.

Johnson & Johnson (NYSE:JNJ – Get Free Report) last announced its quarterly earnings data on Wednesday, August 30th. The company reported $2.26 earnings per share for the quarter. Johnson & Johnson had a net margin of 27.26% and a return on equity of 32.73%. The firm had revenue of $24.02 billion for the quarter. On average, equities research analysts expect that Johnson & Johnson will post 10.58 earnings per share for the current fiscal year.

Johnson & Johnson Company Profile

(Get Free Report)

Johnson & Johnson is a multinational healthcare company headquartered in New Brunswick, New Jersey, that develops, manufactures and markets a broad range of products across pharmaceuticals, medical devices and previously consumer health. Founded in 1886 by the Johnson family, the company has grown into a global healthcare organization with operations and sales in many countries around the world.

The company’s pharmaceuticals business, organized largely under its Janssen research and development organization, focuses on prescription medicines across therapeutic areas such as immunology, infectious disease, oncology and neuroscience.

Featured Stories